A Clinical Method For Mapping And Quantifying Blood Stasis And Thrombus Risk In The Heart
This technology is patent pending and realized in a demonstrated software package with a small set of patient data supporting efficacy. This technology could be suitable as a software services business and/or an add-on tool for an existing clinical imaging platform.
Given here is an enhanced imaging technique to evaluate a patient’s risk for Stroke based upon quantifiable measures of blood stasis (residence time) in the Left Ventricle. The method is realized in software and leverages existing clinically abundant ultra-sound equipment to provide a clear measure of a patient’s risk factors for a future Stroke based upon present measurements acquired in the clinic. Leveraging this diagnostic, more informed decisions can be made regarding the prescription of blood-thinners, potentially leading to a personalized medicine approach where a diagnostic such as this becomes a requirement before subjecting someone to a lifetime of expensive and risky anti-coagulant therapy.
20170150928
Related Materials Tech ID/UC Case 25745/2016-003-0 Related Cases 2016-003-0
美国
